These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33485926)

  • 1. Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019.
    MacLachlan TK; Price S; Cavagnaro J; Andrews L; Blanset D; Cosenza ME; Dempster M; Galbreath E; Giusti AM; Heinz-Taheny KM; Fleurance R; Sutter E; Leach MW
    Regul Toxicol Pharmacol; 2021 Apr; 121():104872. PubMed ID: 33485926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directions.
    Leach MW; Halpern WG; Johnson CW; Rojko JL; MacLachlan TK; Chan CM; Galbreath EJ; Ndifor AM; Blanset DL; Polack E; Cavagnaro JA
    Toxicol Pathol; 2010 Dec; 38(7):1138-66. PubMed ID: 20926828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey results on the use of the tissue cross-reactivity immunohistochemistry assay.
    Bussiere JL; Leach MW; Price KD; Mounho BJ; Lightfoot-Dunn R
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):493-502. PubMed ID: 20951178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical development of monoclonal antibodies: considerations for the use of non-human primates.
    Chapman K; Pullen N; Coney L; Dempster M; Andrews L; Bajramovic J; Baldrick P; Buckley L; Jacobs A; Hale G; Green C; Ragan I; Robinson V
    MAbs; 2009; 1(5):505-16. PubMed ID: 20065651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the reactivity of commercially available monoclonal antibodies with equine cytokines.
    Schnabel CL; Wagner S; Wagner B; Durán MC; Babasyan S; Nolte I; Pfarrer C; Feige K; Murua Escobar H; Cavalleri JM
    Vet Immunol Immunopathol; 2013 Nov; 156(1-2):1-19. PubMed ID: 24139393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of monoclonal antibodies improves immunohistochemical diagnosis of Neospora caninum.
    Uzêda RS; Schares G; Ortega-Mora LM; Madruga CR; Aguado-Martinez A; Corbellini LG; Driemeier D; Gondim LF
    Vet Parasitol; 2013 Nov; 197(3-4):477-86. PubMed ID: 23927916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of monoclonal antibodies to West Nile virus and their application in immunohistochemistry.
    Hirota J; Shimizu S; Shibahara T; Isobe T; Yamada M; Tanimura N
    Clin Vaccine Immunol; 2012 Nov; 19(11):1853-8. PubMed ID: 22993408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of murine monoclonal antibodies for the immunohistochemical diagnosis of systemic bovine aspergillosis.
    Jensen HE; Halbaek B; Lind P; Krogh HV; Frandsen PL
    J Vet Diagn Invest; 1996 Jan; 8(1):68-75. PubMed ID: 9026084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology.
    Ma D; Baruch D; Shu Y; Yuan K; Sun Z; Ma K; Hoang T; Fu W; Min L; Lan ZS; Wang F; Mull L; He WW
    BMC Biotechnol; 2012 Nov; 12():88. PubMed ID: 23171216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations regarding nonhuman primate use in safety assessment of biopharmaceuticals.
    Buckley LA; Chapman K; Burns-Naas LA; Todd MD; Martin PL; Lansita JA
    Int J Toxicol; 2011 Oct; 30(5):583-90. PubMed ID: 22013138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMA031, a monoclonal antibody suited to identify the T-cell receptor alpha beta/CD3 complex on viable human T lymphocytes in normal and disease states.
    Borst J; van Dongen JJ; de Vries E; Comans-Bitter WM; van Tol MJ; Vossen JM; Kurrle R
    Hum Immunol; 1990 Nov; 29(3):175-88. PubMed ID: 1704361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct immunogenic epitopes on the alpha chain of human T cell antigen receptor.
    Henry L; Tian WT; Rittershaus C; Ko JL; Marsh HC; Ip SH
    Hybridoma; 1989 Dec; 8(6):577-88. PubMed ID: 2482248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate approaches in development of monoclonal antibodies.
    Bornstein GG; Klakamp SL; Andrews L; Boyle WJ; Tabrizi M
    Drug Discov Today; 2009 Dec; 14(23-24):1159-65. PubMed ID: 19853060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies.
    Kong X; Wan JB; Hu H; Su S; Hu Y
    MAbs; 2017 Oct; 9(7):1041-1051. PubMed ID: 28737444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory forum opinion piece*: tissue cross-reactivity studies: what constitutes an adequate positive control and how do we report positive staining?
    Geoly FJ
    Toxicol Pathol; 2014 Aug; 42(6):954-6. PubMed ID: 23847038
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of emerging safety biomarkers in nonclinical and clinical safety assessment - The current and future state: An IQ DruSafe industry survey.
    Zabka TS; Burkhardt J; Reagan WJ; Gautier JC; Glaab WE; Guffroy M; Harding J; Brees D; McDuffie E; Ramaiah L; Schultze AE; Smith JD; Wolfreys A; Dalmas DA
    Regul Toxicol Pharmacol; 2021 Mar; 120():104857. PubMed ID: 33387566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach to characterize host cell proteins associated with therapeutic monoclonal antibodies.
    Thomson AS; Mai S; Byrne MP
    Biotechnol Bioeng; 2017 Jun; 114(6):1208-1214. PubMed ID: 28112396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro secondary pharmacological profiling: An IQ-DruSafe industry survey on current practices.
    Valentin JP; Guillon JM; Jenkinson S; Kadambi V; Ravikumar P; Roberts S; Rosenbrier-Ribeiro L; Schmidt F; Armstrong D
    J Pharmacol Toxicol Methods; 2018; 93():7-14. PubMed ID: 30030184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
    Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
    J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.